|
|
Prepublished online as a Blood First Edition Paper on August 7, 2003; DOI 10.1182/blood-2003-05-1522.

Submitted May 14, 2003
Accepted August 1, 2003
5 1 integrin as a cellular co-receptor for human parvovirus B19: requirement of functional activation of 1 integrin for viral entry
Kirsten A Weigel-Kelley, Mervin C Yoder, and Arun Srivastava*
Department of Microbiogy & Immunology, Walther Oncology Center, Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
Departments of Pediatrics and Biochemistry & Molecular Biology, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA
* Corresponding author; email: asrivast{at}iupui.edu.
Replication of the pathogenic human parvovirus B19 is restricted to erythroid progenitor cells. Although blood group P antigen has been reported to be the cell surface receptor for parvovirus B19, a number of non-erythroid cells, which express P antigen, are not permissive for parvovirus B19 infection. We have documented that P antigen is necessary for parvovirus B19 binding, but not sufficient for virus entry into cells. To test whether parvovirus B19 utilizes a cell surface co-receptor for entry, we used human erythroleukemia cells (K562), which allow parvovirus B19 binding, but not entry. We report here that upon treatment with phorbol esters, K562 cells become adherent and permissive for parvovirus B19 entry, which is mediated by 5 1 integrins, but only in their high affinity conformation. Mature human red blood cells (RBCs), which express high levels of P antigen, but not 5 1 integrins, bind parvovirus B19, but do not allow viral entry. In contrast, primary human erythroid progenitor cells express high levels of both P antigen and 5 1 integrins, and allow 1 integrin-mediated entry of parvovirus B19. Thus, in a natural course of infection, RBCs are likely exploited for a highly efficient systemic dissemination of parvovirus B19.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Guan, S. Wong, N. Zhi, and J. Qiu
The Genome of Human Parvovirus B19 Can Replicate in Nonpermissive Cells with the Help of Adenovirus Genes and Produces Infectious Virus
J. Virol.,
September 15, 2009;
83(18):
9541 - 9553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bonvicini, C. Filippone, E. Manaresi, M. Zerbini, M. Musiani, and G. Gallinella
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection
J. Gen. Virol.,
December 1, 2008;
89(12):
3034 - 3038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bonsch, C. Kempf, and C. Ros
Interaction of Parvovirus B19 with Human Erythrocytes Alters Virus Structure and Cell Membrane Integrity
J. Virol.,
December 1, 2008;
82(23):
11784 - 11791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Guan, F. Cheng, Y. Yoto, S. Kleiboeker, S. Wong, N. Zhi, D. J. Pintel, and J. Qiu
Block to the Production of Full-Length B19 Virus Transcripts by Internal Polyadenylation Is Overcome by Replication of the Viral Genome
J. Virol.,
October 15, 2008;
82(20):
9951 - 9963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pillet, S. Fichelson, F. Morinet, N. S. Young, N. Zhi, and S. Wong
Human B19 Erythrovirus In Vitro Replication: What's New?
J. Virol.,
September 1, 2008;
82(17):
8951 - 8953.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wong, N. Zhi, C. Filippone, K. Keyvanfar, S. Kajigaya, K. E. Brown, and N. S. Young
Ex Vivo-Generated CD36+ Erythroid Progenitors Are Highly Permissive to Human Parvovirus B19 Replication
J. Virol.,
March 1, 2008;
82(5):
2470 - 2476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Waldman and J. B. Kopp
Parvovirus B19 and the Kidney
Clin. J. Am. Soc. Nephrol.,
July 1, 2007;
2(Supplement_1):
S47 - S56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Kerr and N. Boschetti
Short regions of sequence identity between the genomes of human and rodent parvoviruses and their respective hosts occur within host genes for the cytoskeleton, cell adhesion and Wnt signalling
J. Gen. Virol.,
December 1, 2006;
87(12):
3567 - 3575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lupescu, C.-T. Bock, P. A. Lang, S. Aberle, H. Kaiser, R. Kandolf, and F. Lang
Phospholipase A2 Activity-Dependent Stimulation of Ca2+ Entry by Human Parvovirus B19 Capsid Protein VP1
J. Virol.,
November 15, 2006;
80(22):
11370 - 11380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Asokan, J. B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R. J. Samulski
Adeno-Associated Virus Type 2 Contains an Integrin {alpha}5{beta}1 Binding Domain Essential for Viral Cell Entry.
J. Virol.,
September 1, 2006;
80(18):
8961 - 8969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Esfandiarei, A. Suarez, A. Amaral, X. Si, M. Rahmani, S. Dedhar, and B. M. McManus
Novel Role for Integrin-Linked Kinase in Modulation of Coxsackievirus B3 Replication and Virus-Induced Cardiomyocyte Injury
Circ. Res.,
August 18, 2006;
99(4):
354 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Norja, K. Hokynar, L.-M. Aaltonen, R. Chen, A. Ranki, E. K. Partio, O. Kiviluoto, I. Davidkin, T. Leivo, A. M. Eis-Hubinger, et al.
Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue
PNAS,
May 9, 2006;
103(19):
7450 - 7453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lopez-Bueno, M.-P. Rubio, N. Bryant, R. McKenna, M. Agbandje-McKenna, and J. M. Almendral
Host-Selected Amino Acid Changes at the Sialic Acid Binding Pocket of the Parvovirus Capsid Modulate Cell Binding Affinity and Determine Virulence
J. Virol.,
February 1, 2006;
80(3):
1563 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fujii, S.-i. Numata, Y. Nakamura, T. Honda, K. Furukawa, T. Urano, J. Wiels, M. Uchikawa, N. Ozaki, S.-i. Matsuo, et al.
Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products
Glycobiology,
December 1, 2005;
15(12):
1257 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Marttila, D. Persson, D. Gustafsson, M. K. Liszewski, J. P. Atkinson, G. Wadell, and N. Arnberg
CD46 Is a Cellular Receptor for All Species B Adenoviruses except Types 3 and 7
J. Virol.,
November 15, 2005;
79(22):
14429 - 14436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Munakata, T. Saito-Ito, K. Kumura-Ishii, J. Huang, T. Kodera, T. Ishii, Y. Hirabayashi, Y. Koyanagi, and T. Sasaki
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection
Blood,
November 15, 2005;
106(10):
3449 - 3456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kaufmann, A. A. Simpson, and M. G. Rossmann
The structure of human parvovirus B19
PNAS,
August 10, 2004;
101(32):
11628 - 11633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Corcoran and S. Doyle
Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19
J. Med. Microbiol.,
June 1, 2004;
53(6):
459 - 475.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|